Form 8.3

Summary by AI BETAClose X

Qube Research & Technologies Limited disclosed on 04-11-2026 that as at 03-11-2026 it holds cash-settled derivative exposure to 4,512,682 Intertek 1p ordinary shares, representing 2.93% of voting rights, with 0 direct holdings and no stock-settled derivatives or subscription rights; the position reflects multiple equity-swap transactions (increasing and decreasing long and short exposures) executed at prices around 5,930–5,940 GBp, and the filing states there are no indemnities, option arrangements or agreements affecting voting rights or future acquisition.

Disclaimer*

UK 100

Latest directors dealings